Evidence map›Paper›PMID 28718674›Full record

ArticleJournal of enzyme inhibition and medicinal chemistry2017

Design and synthesis of a novel photoaffinity probe for labelling EGF receptor tyrosine kinases.

You-Guang Zheng, Xiao-Qing Wu, Jun Su, Ping Jiang, Liang Xu, Jian Gao, Bin Cai, Min Ji

Open access · goldAbstract read
In one paragraph

Article in Journal of enzyme inhibition and medicinal chemistry, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.1field-weighted citation impact, top 54% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 6 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

You-Guang Zhenga College of Pharmacy , Xuzhou Medical University , Xuzhou , PR China.
Xiao-Qing Wub Departments of Molecular Biosciences and Radiation Oncology , University of Kansas , Lawrence , KS , USA.
Jun Sua College of Pharmacy , Xuzhou Medical University , Xuzhou , PR China.
Ping Jianga College of Pharmacy , Xuzhou Medical University , Xuzhou , PR China.
Liang Xub Departments of Molecular Biosciences and Radiation Oncology , University of Kansas , Lawrence , KS , USA.
Jian Gaoa College of Pharmacy , Xuzhou Medical University , Xuzhou , PR China.
Bin Caia College of Pharmacy , Xuzhou Medical University , Xuzhou , PR China.
Min Jic School of Chemistry and Chemical Engineering , Southeast University , Nanjing , PR China.
Xuzhou Medical College · CNUniversity of Kansas · USSoutheast University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The epidermal growth factor receptor (EGFR) and HER2 are two important tyrosine kinases that play crucial roles in signal transduction pathways that regulate numerous cellular functions including proliferation, differentiation, migration, and angiogenesis. In the past 20 years, many proteomic methods have emerged as powerful methods to evaluate proteins in biological processes and human disease states. Among them, activity-based protein profiling (ABPP) is one useful approach for the functional analysis of proteins. In this study, a novel photoaffinity probe 11 was designed and synthesised to assess the target profiling of the reactive group in the photoaffinity probe 11. Biological evaluation was performed, and the results showed that the novel photoaffinity probe binds to EGFR and HER2 proteins and it hits targets by the reactive group.

Indexed as

Drug DesignCell Line, TumorErbB ReceptorsHumansMolecular Docking SimulationMolecular StructurePhotoaffinity LabelsQuinazolinesStructure-Activity RelationshipEGFR protein, humanErbB ReceptorsPhotoaffinity LabelsQuinazolinesactivity-based protein profilingEpidermal growth factor receptorphotoaffinity probe

Identifiers

PMID28718674
PMCPMC6009917
OpenAlexW2736982901

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.